14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Mon, 6 May 2024

Trading levels for 1801.HK

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 44.95 7.41 %
R2 43.23 3.30 %
R1 42.17 0.762 %
Current price: 41.85
Support S1 38.73 -7.45 %
S2 37.67 -9.99 %
S3 35.95 -14.10 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 43.85 4.78 %
R2 42.65 1.91 %
R1 42.35 1.19 %
Current price 41.85
Support S1 41.35 -1.19%
S2 36.00 -13.98%
S3 33.00 -21.15%

1801.HK Predictions History

StockInvest.us BE THE FIRST TO PREDICT

The excellent way of becoming a better trader


  • Easy to use
  • Enhance your skills
  • Predict as many as you like
  • Request predictions
  • Gather points
  • Learn to time your buy and sells

I wonder how good you are and if you can beat me?

Now it is your turn to become professional by doing what professionals do - Exercise

Best regards,

Jim - Co-founder of StockInvest.us [ See tutorial video ]

Click to get the best stock tips daily for free!

About Innovent Biologics, Inc.

Innovent Biologics. Innovent Biologics, Inc. operates as a biopharmaceutical company in China. The company operates a platform for the discovery, development, and manufacture of antibody drug candidates in the fields of oncology, ophthalmology, immunology, and metabolic diseases. Its principal drug candidate is Tyvyt (sintilimab), an anti-PD-1 monoclonal antibody for the treatment of cancer, Hodgkin's lymphoma, and esophageal carcinoma. The company also offers Byvas... 1801.HK Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT